Table 1.
Patients’ characteristics.
| Variable | Study Group (n = 93) n (%) or Median (Range) |
|---|---|
| Sex | |
| Men | 60 (64.5%) |
| Women | 33 (35.5%) |
| Age | 61 (32–83) |
| Lauren’s type | |
| Intestinal | 45 (49.5%) |
| Mixed | 22 (24.2%) |
| Diffuse | 24 (26.4%) |
| Tumor localization | |
| U | 22 (23.66%) |
| M | 43 (46.2%) |
| L | 28 (30.1%) |
| (y)pT | |
| 0 | 4 (4.3%) |
| 1 | 7 (7.6%) |
| 2 | 19 (20.4%) |
| 3 | 48 (51.6%) |
| 4 | 15 (16.1%) |
| (y)pN | |
| 0 | 41 (44.1%) |
| 1 | 14 (15.1%) |
| 2 | 13 (14%) |
| 3a | 9 (9.7%) |
| 3b | 16 (17.2%) |
| Grading | |
| G1 | 5 (5.4%) |
| G2 | 42 (45.2%) |
| G3 | 46 (49.5%) |
| Neoadjuvant chemotherapy | |
| Yes | 79 (84.9%) |
| No | 14 (15.1%) |
| No. of neoadjuvant chemotherapy cycles | 3 (2–8) |
| Tumor regression grade | |
| 1 | 4 (5.2%) |
| 2 | 12 (15.6%) |
| 3 | 36 (46.8%) |
| 4 | 25 (32.5%) |
| N/A: n = 14 | |
| No data: n = 2 | |
| Type of gastrectomy | |
| Proximal | 21 (22.6%) |
| Distal | 33 (35.5%) |
| Total | 39 (41.9%) |
| Surgical margin | |
| R0 | 85 (91.4%) |
| R1 | 8 (8.6%) |
| CCI | 20.9 (0–100) |
| Postoperative complications | |
| No | 67 (72%) |
| Yes | 26 (28%) |
| Unplanned ICU | |
| No | 77 (82.8%) |
| Yes | 16 (17.2%) |
| ICU stay [days] | 2.5 (1–9) |
| TO | |
| No | 44 (47.8%) |
| Yes | 48 (52.2%) |
| No data: n = 1 | |
| Adjuvant chemotherapy | |
| No | 28 (35%) |
| Yes | 52 (65%) |
| No data: n = 13 |
N—number, U—upper, M—median, L—lower, ypT—post-neoadjuvant pathological tumor stage, ypN—post-neoadjuvant pathological nodal stage, CCI—comprehensive complication index, ICU—intensive care unit, TO—textbook outcome.